Celebrex In Acute Gouty Arthritis Study

Clinical trial NCT00549549 · COMPLETED

Trial details

NCT number: NCT00549549
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Arthritis, Gouty

Start date: 2008-02-01
Primary completion: 2009-12-01
Enrollment: 402

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.